SCHEMBL18525632

SCHEMBL18525632

N#CCC(=O)N1CCC[C@@H](O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
JAK3 P52333 13/20 0.42
JAK2 O60674 12/20 0.42
JAK1 P23458 8/20 0.42
TYK2 P29597 4/20 0.42
DPP4 P27487 1/20 0.41
LMNA P02545 1/20 0.40
MAP4K3 Q8IVH8 1/20 0.38
MAP4K5 Q9Y4K4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20183292 0.81 ALDH1A1 (0.42) ALDH1A1MEN1MAPTKMT2AJAK3
SCHEMBL12957767 0.81 ALDH1A1 (0.63) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL13724137 0.81 JAK3 (0.44) ALDH1A1MEN1MAPTKMT2AJAK3
SCHEMBL14644693 0.81 ALDH1A1 (0.63) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL14426034 0.81 ALDH1A1 (0.63) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL22620113 0.81 JAK3 (0.44) ALDH1A1MEN1MAPTKMT2AJAK3
SCHEMBL1899294 0.81 ALDH1A1 (0.38) ALDH1A1MEN1MAPTKMT2AJAK3
SCHEMBL22370793 0.80 JAK2 (0.47) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL22370790 0.80 JAK2 (0.47) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL27266866 0.80 ALDH1A1 (0.50) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017025849-A1 BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS PFIZER INC. (US) 2017-02-16 WO disclosed